Leading up to this month’s Heart Rhythm 2021 Scientific Sessions, Innovative Health, Inc. announced several new initiatives to increase savings from single-use device reprocessing in the electrophysiology (EP) lab.
The company has formed an Emerging Technologies team, charged with developing new reprocessing technologies that will enable cost-savings to be realized on more devices, modalities and clinical areas. Simultaneously, the company has launched a Clinical Integration team that will be working directly with EP labs to align clinical, technological, and administrative goals in order to simultaneously optimize savings and patient care quality.
“Single-use device reprocessing has been successfully proven to generate substantial savings for participating cardiology programs,” said Innovative Health CEO Rick Ferreira. “To realize higher savings, we need to continue to develop our technology and work with our partners to ensure savings are maximized. This is an important investment in the future of reprocessing.” . . .
Visit HPNonline.com for the full article.